6 employees
Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients.
2015
$3M
from 2 investors over 2 rounds
Atlas Molecular Pharma raised $3M on February 1, 2022
Investors: Inveready
Atlas Molecular Pharma raised undisclosed on January 1, 2016
Investors: Kereon Partners